Similar articles for PMID: 19056576

Year	Number of Results
1995	1
1997	1
1998	2
1999	1
2000	4
2001	3
2003	2
2004	2
2005	7
2006	8
2007	14
2008	8
2009	3
2010	8
2011	6
2012	5
2013	8
2014	4
2015	9
2016	9
2017	4
2018	8
2020	3
2021	1
2022	2
2024	0

1

Effects of novel capsinoid treatment on fatness and energy metabolism in humans: possible pharmacogenetic implications.

Snitker S, Fujishima Y, Shen H, Ott S, Pi-Sunyer X, Furuhata Y, Sato H, Takahashi M. Snitker S, et al. Am J Clin Nutr. 2009 Jan;89(1):45-50. doi: 10.3945/ajcn.2008.26561. Epub 2008 Dec 3. Am J Clin Nutr. 2009. PMID: 19056576 Free PMC article. Clinical Trial.

2

Capsinoids activate brown adipose tissue (BAT) with increased energy expenditure associated with subthreshold 18-fluorine fluorodeoxyglucose uptake in BAT-positive humans confirmed by positron emission tomography scan.

Sun L, Camps SG, Goh HJ, Govindharajulu P, Schaefferkoetter JD, Townsend DW, Verma SK, Velan SS, Sun L, Sze SK, Lim SC, Boehm BO, Henry CJ, Leow MK. Sun L, et al. Am J Clin Nutr. 2018 Jan 1;107(1):62-70. doi: 10.1093/ajcn/nqx025. Am J Clin Nutr. 2018. PMID: 29381803 Free article.

3

Nonpungent capsaicin analogs (capsinoids) increase energy expenditure through the activation of brown adipose tissue in humans.

Yoneshiro T, Aita S, Kawai Y, Iwanaga T, Saito M. Yoneshiro T, et al. Am J Clin Nutr. 2012 Apr;95(4):845-50. doi: 10.3945/ajcn.111.018606. Epub 2012 Feb 29. Am J Clin Nutr. 2012. PMID: 22378725 Free article. Clinical Trial.

4

Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial.

Mielgo-Ayuso J, Barrenechea L, Alcorta P, Larrarte E, Margareto J, Labayen I. Mielgo-Ayuso J, et al. Br J Nutr. 2014 Apr 14;111(7):1263-71. doi: 10.1017/S0007114513003784. Epub 2013 Dec 3. Br J Nutr. 2014. PMID: 24299662 Clinical Trial.

5

The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension.

Tremblay A, Chaput JP, Bérubé-Parent S, Prud'homme D, Leblanc C, Alméras N, Després JP. Tremblay A, et al. Eur J Clin Pharmacol. 2007 Feb;63(2):123-34. doi: 10.1007/s00228-006-0220-1. Epub 2007 Jan 3. Eur J Clin Pharmacol. 2007. PMID: 17200837 Clinical Trial.

6

Regulation of uncoupling protein (UCP) 2 and 3 in adipose and muscle tissue by fasting and growth hormone treatment in obese humans.

Pedersen SB, Borglum JD, Kristensen K, Norrelund H, Otto J, Jorgensen L, Richelsen B. Pedersen SB, et al. Int J Obes Relat Metab Disord. 2000 Aug;24(8):968-75. doi: 10.1038/sj.ijo.0801265. Int J Obes Relat Metab Disord. 2000. PMID: 10951534 Clinical Trial.

7

Capsaicin as an anti-obesity drug.

Leung FW. Leung FW. Prog Drug Res. 2014;68:171-9. doi: 10.1007/978-3-0348-0828-6_7. Prog Drug Res. 2014. PMID: 24941669 Review.

8

Effects of Capsinoids on Daily Physical Activity, Body Composition and Cold Hypersensitivity in Middle-Aged and Older Adults: A Randomized Study.

Yokoyama K, Yamada Y, Akamatsu Y, Yoshinaka Y, Yamamoto A, Koizumi T, Ohyama K, Suzuki K, Hashimoto M, Sato H, Kimura M. Yokoyama K, et al. Nutrients. 2020 Jan 14;12(1):212. doi: 10.3390/nu12010212. Nutrients. 2020. PMID: 31947529 Free PMC article. Clinical Trial.

9

A combination of exercise and capsinoid supplementation additively suppresses diet-induced obesity by increasing energy expenditure in mice.

Ohyama K, Nogusa Y, Suzuki K, Shinoda K, Kajimura S, Bannai M. Ohyama K, et al. Am J Physiol Endocrinol Metab. 2015 Feb 15;308(4):E315-23. doi: 10.1152/ajpendo.00354.2014. Epub 2014 Dec 16. Am J Physiol Endocrinol Metab. 2015. PMID: 25516550 Free PMC article.

10

Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns.

Karhunen L, Franssila-Kallunki A, Rissanen P, Valve R, Kolehmainen M, Rissanen A, Uusitupa M. Karhunen L, et al. Int J Obes Relat Metab Disord. 2000 Dec;24(12):1567-72. doi: 10.1038/sj.ijo.0801443. Int J Obes Relat Metab Disord. 2000. PMID: 11126207 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

105 results

Results by year